Publication
Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies.
Authors not recorded
- Source
- PubMed
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CIVIC-20260908-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Data not yet available
Linked entities
Linked entities (6)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 6
- cancerMalignant Neoplasmcivic_curation1.00
- drugAngiogenesis Inhibitorcivic_curation1.00
- geneECSCRcivic_curation1.00
- geneROBO4civic_curation1.00
- variantECSCR EXPRESSIONcivic_curation1.00
- variantROBO4 EXPRESSIONcivic_curation1.00
Curated evidence
Evidence citing this paper (2)
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 26956051
- Run
- ING-CIVIC-20260908-000001
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| ECSCR EXPRESSION1 | ||||||||
| Angiogenesis Inhibitor | Malignant NeoplasmALIAS | Predictive | B | Does Not Support Sensitivity Response | 1 | accepted | EID1165Biomarkers for response to antiangiogenic treatment were screened for in hepatocellular cancer (n = 11), renal cell cancer (n = 7) and non-small cell lung cancer (n = 2). Increased expression of tumor… (full text at CIViC) PMID 26956051 · Pircher et al., 2016 · Open in CIViC | civic |
| ROBO4 EXPRESSION1 | ||||||||
| Angiogenesis Inhibitor | Malignant NeoplasmALIAS | Predictive | B | Does Not Support Sensitivity Response | 1 | accepted | EID1166Biomarkers for Response to antiangiogenic treatment were screened for in hepatocellular cancer (n = 11), renal cell cancer (n = 7) and non-small cell lung cancer (n = 2). Increased expression of tumor… (full text at CIViC) PMID 26956051 · Pircher et al., 2016 · Open in CIViC | civic |